Loading...
Loading...
EOLS| Name | Value |
|---|---|
| Revenues | 69.0M |
| Cost of Revenue | 23.1M |
| Gross Profit | 45.8M |
| Operating Expense | 54.9M |
| Operating I/L | -11.5M |
| Other Income/Expense | -4.1M |
| Interest Income | 0.5M |
| Pretax | -15.6M |
| Income Tax Expense | -0.2M |
| Net Income/Loss | -15.7M |
Evolus, Inc. is a performance beauty company that provides medical aesthetic products, primarily focusing on Jeuveau, a botulinum toxin type A formulation for improving the appearance of glabellar lines in adults. The company generates revenue by selling Jeuveau to physicians for use in their patients' aesthetic treatments.
